Financial Performance - The company reported a basic earnings per share of -0.0600 yuan for Q1 2025, an improvement of 25% compared to -0.0800 yuan in Q1 2024, but a decline from 0.0500 yuan in Q1 2023 [1] - The net profit for Q1 2025 was -0.06 billion yuan, showing a 25% improvement from -0.08 billion yuan in Q1 2024, but a decrease from 0.04 billion yuan in Q1 2023 [1] - The operating revenue increased by 33.33% to 0.4 billion yuan in Q1 2025 from 0.3 billion yuan in Q1 2024, but decreased from 0.59 billion yuan in Q1 2023 [1] - The return on equity was -0.54% in Q1 2025, an improvement from -0.72% in Q1 2024, but a decline from 1.17% in Q1 2023 [1] Shareholder Structure - The top ten unrestricted shareholders collectively hold 2.7582 million shares, accounting for 7.1% of the circulating shares, with a decrease of 1.2615 million shares compared to the previous period [1] - Notable changes in the top shareholders include the entry of Zhao Yongzhang, Chen Liping, and Chu Yazhou, while Sun Chengli, Zhou Lei, and Zhao Chen exited the top ten shareholders [2] Dividend Policy - The company has decided not to distribute dividends or transfer shares in this period [3]

Financial Performance - The company reported a basic earnings per share of 0.0130 yuan for Q1 2025, a significant increase of 6600% compared to a loss of 0.0002 yuan in Q1 2024 [1] - Operating revenue for Q1 2025 was 1.86 billion yuan, representing a 58.97% increase from 1.17 billion yuan in Q1 2024 [1] - Net profit for Q1 2025 was 0.05 billion yuan, compared to no profit in Q1 2024 [1] - The return on equity (ROE) improved to 0.30% in Q1 2025 from a negative 0.0050% in Q1 2024 [1] Shareholder Structure - The top ten unrestricted shareholders hold a total of 30,183.91 million shares, accounting for 80.2% of the circulating shares, with an increase of 352.03 million shares from the previous period [1] - The largest shareholder, China Railway Electric Industry Co., Ltd., holds 26,868.16 million shares, representing 71.40% of the total share capital, with no change in holdings [2] - Notable changes include an increase of 194.65 million shares held by Li Shengjun and 123.12 million shares held by Cao Dong [2] Dividend Policy - The company has announced that it will not distribute dividends or bonus shares this time [3]

Financial Performance - The company reported a basic earnings per share of 0.1700 yuan for Q1 2025, representing a 13.33% increase compared to 0.1500 yuan in Q1 2024 [1] - The net profit for Q1 2025 was 0.96 billion yuan, up 17.07% from 0.82 billion yuan in Q1 2024 [1] - The operating revenue for Q1 2025 reached 6.27 billion yuan, a 23.18% increase from 5.09 billion yuan in Q1 2024 [1] - The return on equity decreased to 2.80% in Q1 2025 from 3.63% in Q1 2024, a decline of 22.87% [1] Shareholder Structure - The top ten unrestricted shareholders hold a total of 13,313.51 million shares, accounting for 24.34% of the circulating shares, which is a decrease of 305.19 million shares from the previous period [1] - Notable shareholders include Shen Jie with 5,613.61 million shares (10.26%), and Nanjing University Capital Operation Co., Ltd. with 1,909.00 million shares (3.49%) [2] - New entrants among the top shareholders include China Industrial Bank's ETF with 1,247.92 million shares (2.28%) [2] Dividend Distribution - The company has announced that there will be no distribution or transfer of dividends this time [3]

前十大流通股东累计持有： 228331.34万股，累计占流通股比： 67.61%，较上期变化： -5023.29万股。 一、主要会计数据和财务指标 | 报告期指标 | 2025年一季报 | 2024年一季报 | 本年比上年增减(%) | 2023年一季报 | | --- | --- | --- | --- | --- | | 基本每股收益（元） | -0.0100 | 0.0100 | -200 | 0.0100 | | 每股净资产（元） | 0 | 5.99 | -100 | 5.99 | | 每股公积金(元) | 2.97 | 2.97 | 0 | 2.97 | | 每股未分配利润(元) | 1.50 | 1.76 | -14.77 | 1.76 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 144.37 | 160.43 | -10.01 | 124.88 | | 净利润(亿元) | -0.35 | 0.34 | -202.94 | 0.32 | | 净资产收益率(%) | -0.18 | 0.17 | -205.88 | 0.16 | 数据四舍五入，查看更 ...

近期福安药业（300194）发布2025年一季报，证券之星财报模型分析如下： 经营业绩 近期福安药业发布的2025年一季报显示，公司业绩出现明显下滑。具体来看，截至本报告期末，公司营 业总收入为4.68亿元，同比下降42.22%；归母净利润为6904.9万元，同比下降43.63%；扣非净利润为 6568.48万元，同比下降43.8%。 单季度数据 主营分类 主营构成 主营收入 收入占比 主营利润 利润占比 毛利率 财务分析 业务评价 证券之星价投圈财报分析工具显示，公司去年的ROIC为5.36%，近年资本回报率一般。公司业绩具有周 期性。去年的净利率为11.63%，算上全部成本后，公司产品或服务的附加值一般。 从单季度数据来看，2025年第一季度营业总收入为4.68亿元，同比下降42.22%；归母净利润为6904.9万 元，同比下降43.63%；扣非净利润为6568.48万元，同比下降43.8%。 主要财务指标 本次财报公布的各项数据指标表现不尽如人意。具体如下： 主营收入构成 根据财报，福安药业的主营收入构成如下表所示： 融资分红 公司自上市以来，累计融资总额为34.66亿元，累计分红总额为6.05亿元，分 ...

Financial Performance - The company's basic earnings per share decreased by 40% to 0.0900 yuan in Q1 2025 compared to 0.1500 yuan in Q1 2024 [1] - Net profit fell by 40.42% to 3.39 billion yuan in Q1 2025 from 5.69 billion yuan in Q1 2024 [1] - Operating revenue decreased by 7.3% to 28.69 billion yuan in Q1 2025, down from 30.95 billion yuan in Q1 2024 [1] - The return on equity dropped by 43.93% to 2.31% in Q1 2025, compared to 4.12% in Q1 2024 [1] Shareholder Structure - The top ten unrestricted shareholders hold a total of 118,354.96 million shares, accounting for 35.61% of the circulating shares, with a decrease of 504.77 million shares from the previous period [1] - Inner Mongolia Boyuan Holding Group Co., Ltd. remains the largest shareholder with 78,901.64 million shares, representing 23.73% of total share capital [2] - New entrants among the top shareholders include the National Social Security Fund's 112th portfolio, holding 4,838.22 million shares, which accounts for 1.46% [2] Dividend Policy - The company has decided not to distribute dividends or transfer shares in this period [3]

一、主要会计数据和财务指标 | 报告期指标 | 2025年一季报 | 2024年一季报 | 本年比上年增减(%) | 2023年一季报 | | --- | --- | --- | --- | --- | | 基本每股收益（元） | -0.0600 | -0.0700 | 14.29 | -0.1000 | | 每股净资产（元） | 4.22 | 4.59 | -8.06 | 4.97 | | 每股公积金(元) | 4.25 | 4.24 | 0.24 | 4.15 | | 每股未分配利润(元) | -1.07 | -0.70 | -52.86 | -0.24 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 10.59 | 8.29 | 27.74 | 3.99 | | 净利润(亿元) | -0.98 | -1.07 | 8.41 | -1.24 | | 净资产收益率(%) | -1.42 | -1.44 | 1.39 | -1.99 | 数据四舍五入，查看更多财务数据>> 二、前10名无限售条件股东持股情况 前十大流通股东累计持有： 27817.41万股，累计占流通 ...

前十大流通股东累计持有： 23258.81万股，累计占流通股比： 30.28%，较上期变化： -2704.67万股。 | 名称 持有数量(万股) | | 占总股本比例(%) | 增减情况(万股) | | --- | --- | --- | --- | | 万裕文化产业有限公司 | 10691.01 | 13.92 | 不变 | | 陕西烟草投资管理有限公司 | 3617.94 | 4.71 | 不变 | | 陈启来 | 2940.58 | 3.83 | -2387.14 | | 重庆金嘉兴实业有限公司 | 2731.56 | 3.56 | 不变 | | 陕西中烟投资管理有限公司 | 1590.88 | 2.07 | 不变 | | 银河德睿资本管理有限公司 | 477.48 | 0.62 | -301.48 | | 中国银河（601881）证券股份有限公司 | 394.85 | 0.51 | 新进 | | 湖北中烟工业有限责任公司 | 354.58 | 0.46 | 不变 | | 刘章 | 250.00 | 0.33 | 新进 | | 何小春 | 209.93 | 0.27 | -65.68 | | 较上个报告 ...

一、主要会计数据和财务指标 前十大流通股东累计持有： 9699.25万股，累计占流通股比： 72.08%，较上期变化： 220.63万股。 | 名称 | 持有数量(万股) | 占总股本比例 (%) | 增减情况(万 股) | | --- | --- | --- | --- | | 曹抗美 | 2514.26 | 18.69 | 不变 | | 上海汇嘉创业投资有限公司 | 1581.36 | 11.75 | 不变 | | 上海安亭实业发展有限公司 | 1130.66 | 8.40 | 不变 | | 吴建良 | 977.77 | 7.27 | 不变 | | 朱燕阳 | 760.29 | 5.65 | 不变 | | 江华 | 558.73 | 4.15 | 不变 | | 戴华淼 | 558.73 | 4.15 | 不变 | | 陈德兴 | 558.73 | 4.15 | 不变 | | 卜晓明 | 558.73 | 4.15 | 不变 | | 西上海（605151）汽车服务股份有限公司-2024年员工 | | | | | 持股计划 | 499.99 | 3.72 | 新进 | | 较上个报告期退出前十大股东有 | | ...

一、主要会计数据和财务指标 | 报告期指标 | 2025年一季报 | 2024年一季报 | 本年比上年增减(%) | 2023年一季报 | | --- | --- | --- | --- | --- | | 基本每股收益（元） | -0.0173 | -0.0230 | 24.78 | -0.0267 | | 每股净资产（元） | 0.69 | 0.67 | 2.99 | 0.02 | | 每股公积金(元) | 1.18 | 1.19 | -0.84 | 1.19 | | 每股未分配利润(元) | -1.65 | -1.67 | 1.2 | -2.32 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 1.36 | 1.72 | -20.93 | 1.06 | | 净利润(亿元) | -0.17 | -0.23 | 26.09 | -0.27 | | 净资产收益率(%) | -2.44 | -3.43 | 28.86 | -83.82 | 数据四舍五入，查看更多财务数据>> 三、分红送配方案情况 本次公司不分配不转赠。 二、前10名无限售条件股东持股情况 前十大流通股 ...